FDA Announces Joint Meeting of Advisory Committees and Public Comment Period

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee to provide advice on regulatory issues. The public is invited to submit comments on the meeting and the proposed docket.